Related references
Note: Only part of the references are listed.A 2-process model for neuropathology of Alzheimer's disease
Dan Mungas et al.
NEUROBIOLOGY OF AGING (2014)
Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults
Niklas Mattsson et al.
NEUROBIOLOGY OF AGING (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Amyloid Imaging With Carbon 11-Labeled Pittsburgh Compound B for Traumatic Brain Injury
Young T. Hong et al.
JAMA NEUROLOGY (2014)
Brain Differences in Infants at Differential Genetic Risk for Late-Onset Alzheimer Disease A Cross-sectional Imaging Study
Douglas C. Dean et al.
JAMA NEUROLOGY (2014)
Reply: the early pathological process in sporadic Alzheimer's disease
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2013)
Amyloid and tau: neither chicken nor egg but two partners in crime!
Johannes Attems et al.
ACTA NEUROPATHOLOGICA (2013)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
Manja Lehmann et al.
BRAIN (2013)
Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation
Marc Teichmann et al.
BRAIN (2013)
SnapShot: Genetics of Alzheimer's Disease
Rita Guerreiro et al.
CELL (2013)
Redundancy and divergence in the amyloid precursor protein family
S. Ali M. Shariati et al.
FEBS LETTERS (2013)
Brain Changes in Older Adults at Very Low Risk for Alzheimer's Disease
Anders M. Fjell et al.
JOURNAL OF NEUROSCIENCE (2013)
A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II
Fiona E. Matthews et al.
LANCET (2013)
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Stephanie J. B. Vos et al.
LANCET NEUROLOGY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Primary progressive aphasia and the language network The 2013 H. Houston Merritt Lecture
M-Marsel Mesulam
NEUROLOGY (2013)
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity
Clifford R. Jack et al.
NEUROLOGY (2013)
Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden
Chengxuan Qiu et al.
NEUROLOGY (2013)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease
Manja Lehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
Krista L. Moulder et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis
David G. Le Couteur et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
N. Mattsson et al.
TRANSLATIONAL PSYCHIATRY (2013)
Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?
Jennifer L. Whitwell et al.
NEUROIMAGE-CLINICAL (2013)
Clinical and multimodal biomarker correlates of ADNI neuropathological findings
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia
Tamar Gefen et al.
BRAIN (2012)
The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
Lucia Chavez-Gutierrez et al.
EMBO JOURNAL (2012)
Dementia From Alzheimer Disease and Mixed Pathologies in the Oldest Old
Bryan D. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease
Jonny Daborg et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging
William J. Jagust et al.
JOURNAL OF NEUROSCIENCE (2012)
Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease
Anders Wallin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Posterior cortical atrophy
Sebastian J. Crutch et al.
LANCET NEUROLOGY (2012)
Neuroimaging Results Impose New Views on Alzheimer's Disease-the Role of Amyloid Revised
Anders M. Fjell et al.
MOLECULAR NEUROBIOLOGY (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
G. Chetelat et al.
NEUROLOGY (2012)
Early-onset Alzheimer disease clinical variants Multivariate analyses of cortical thickness
Gerard R. Ridgway et al.
NEUROLOGY (2012)
Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
Carlos Cruchaga et al.
PLOS ONE (2012)
The pathological process underlying Alzheimer's disease in individuals under thirty
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2011)
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: association with age, hippocampal sclerosis and clinical phenotype
Yvonne S. Davidson et al.
ACTA NEUROPATHOLOGICA (2011)
Clinicopathological Correlations in Corticobasal Degeneration
Suzee E. Lee et al.
ANNALS OF NEUROLOGY (2011)
Prevalence and Pathology of Dementia with Lewy Bodies in the Oldest Old: A Comparison with Other Dementing Disorders
Kurt A. Jellinger et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)
Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'
Rudy J. Castellani et al.
JOURNAL OF PATHOLOGY (2011)
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
J. Li et al.
NEUROLOGY (2011)
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution
M. H. Rosenbloom et al.
NEUROLOGY (2011)
Cerebrospinal Fluid Microglial Markers in Alzheimer's Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
Niklas Mattsson et al.
NEUROMOLECULAR MEDICINE (2011)
Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans
Henrik Zetterberg et al.
PLOS ONE (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β
Maya A. Koike et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Increased Brain Atrophy Rates in Cognitively Normal Older Adults with Low Cerebrospinal Fluid Aβ1-42
Jonathan M. Schott et al.
ANNALS OF NEUROLOGY (2010)
APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
John C. Morris et al.
ANNALS OF NEUROLOGY (2010)
Larger temporal volume in elderly with high versus low beta-amyloid deposition
Gael Chetelat et al.
BRAIN (2010)
Brain Atrophy in Healthy Aging Is Related to CSF Levels of Aβ1-42
Anders M. Fjell et al.
CEREBRAL CORTEX (2010)
Cerebrovascular Hypoperfusion Induces Spatial Memory Impairment, Synaptic Changes, and Amyloid-beta Oligomerization in Rats
Xiaojuan Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
Anders M. Fjell et al.
JOURNAL OF NEUROSCIENCE (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Primary progressive aphasia: clinicopathological correlations
Murray Grossman
NATURE REVIEWS NEUROLOGY (2010)
Homocysteine and holotranscobalamin and the risk of Alzheimer disease A longitudinal study
B. Hooshmand et al.
NEUROLOGY (2010)
Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
Rahul S. Desikan et al.
PLOS ONE (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment
Julie A. Schneider et al.
ANNALS OF NEUROLOGY (2009)
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
E. C. Mormino et al.
BRAIN (2009)
Midlife Serum Cholesterol and Increased Risk of Alzheimer's and Vascular Dementia Three Decades Later
Alina Solomon et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Blood Pressure Components and Changes in Relation to White Matter Lesions A 32-Year Prospective Population Study
Xinxin Guo et al.
HYPERTENSION (2009)
Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-beta Protein Precursor and Amyloid-beta
Rudy J. Castellani et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α
Michela Guglielmotto et al.
JOURNAL OF NEUROCHEMISTRY (2009)
One-Year Brain Atrophy Evident in Healthy Aging
Anders M. Fjell et al.
JOURNAL OF NEUROSCIENCE (2009)
Human APOE Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice
Kelly R. Bales et al.
JOURNAL OF NEUROSCIENCE (2009)
Anatomically-distinct genetic associations of APOE ε4 allele load with regional cortical atrophy in Alzheimer's disease
Nicola Filippini et al.
NEUROIMAGE (2009)
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease
W. J. P. Henneman et al.
NEUROLOGY (2009)
Clinical syndromes associated with posterior atrophy Early age at onset AD spectrum
R. Migliaccio et al.
NEUROLOGY (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis
S. Duke Han et al.
ALZHEIMERS & DEMENTIA (2008)
Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives
Emily Rogalski et al.
ARCHIVES OF NEUROLOGY (2008)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Meta-analysis of APOE4 allele and outcome after traumatic brain injury
Weidong Zhou et al.
JOURNAL OF NEUROTRAUMA (2008)
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Julie A. Schneider et al.
NEUROLOGY (2007)
Two faces of p53: aging and tumor suppression
Francis Rodier et al.
NUCLEIC ACIDS RESEARCH (2007)
Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer's disease presenilin 1 mutation
John S. K. Kauwe et al.
ANNALS OF NEUROLOGY (2007)
Cerebrospinal fluid β-amyloid 1-42 concentration may predict cognitive decline in older women
Deborah R. Gustafson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage
N. A. Martinez-Gonzalez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
The distribution of apolipoprotein E alleles in Scottish perinatal deaths
JC Becher et al.
JOURNAL OF MEDICAL GENETICS (2006)
Regional brain changes in aging healthy adults: General trends, individual differences and modifiers
N Raz et al.
CEREBRAL CORTEX (2005)
Distribution of apolipoprotein E alleles in a Scottish healthy newborn population
JC Becher et al.
BIOLOGY OF THE NEONATE (2005)
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy
DF Tang-Wai et al.
NEUROLOGY (2004)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Influence of the apolipoprotein E ε4 allele on human embryonic development
H Zetterberg et al.
NEUROSCIENCE LETTERS (2002)
Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study
A Ogunniyi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2000)
Share Paper
